Advertisement

 

 

TCT 2013

TCT 2013
Advertisement

New research is being presented at TCT 2013, the 25th anniversary of the Transcatheter Cardiovascular Therapeutics annual meeting, from October 27 to November 1, in San Francisco.

Meeting Highlights

The Effects of Intraprocedural Stent Thrombosis

Hydration Choice Matters for Coronary Angiography

Radial Access PCI Beneficial in Women

 

News From the Meeting

Second Generation Transcatheter Aortic Valve Shown to Successfully Address Complications of TAVR

New Study Evaluates Outcomes of Providing Access to Platelet Function Testing in a Clinical Setting

Removing Blood Clots During PCI Does Not Improve Outcomes Compared With Standard Angioplasty in Patients With NSTEMI

“Hybrid Procedure” Combining Minimally Invasive CABG With PCI Is Feasible and Safe Compared With Traditional CABG

Genetic Profiling may Provide Clinical Benefit by Identifying Heart Attack Patients Who Are Resistant to Blood Thinners

Study Examines the Impact of Insulin Treatment Status in Diabetic Patients With Multivessel Coronary Artery Disease

New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated With Second Generation Drug-Eluting Stent

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiotrity of Newest Zotarolimus-Eluting Stent

Therapeutic Hypothermia Is Safe and Feasible as Adjunctive Care for Heart Attack Patients

New Study Compares Conservative and Aggressive Revascularization Strategies for Coronary Stenting Based Upon Angiography Alone

Trial Examines Benefits of Using a New Test to Determine the Severity of Coronary Artery Disease

Good Outcomes With Both Drug-Eluting Stents and Drug-Eluting Balloons in Treating Patietns With Bare Metal Stent Restenosis

Study Demonstrates High Accuracy of Non-Invasive Computed FFR in Evaluating Patients With Coronary Artery Disease

New Study Examines Safety and Efficacy of Drug-Coated Ballon Angioplasty for Treatmetn of Femoropoliteal Artery Disease

Study Finds Pre-Hospital Administration of Bivalirudin Substantially Improves Outcomes Compared to Heparin in Heart Attack Patients

Clinical Trial Finds that a Strategy of Using a Bare Metal Stent in the Side Branch for True Bifurcation Coronary Lesions Is Safe, but Does Not Meet Non-Inferiority Endpoint Compared to Provisional Stenting

New Study Compares Two Newer Generation Drug-Eluting Stents With Biocompatible and Biodegradable Polymers

New Study Compares Provisional and Two-Stent Strategies for Coronary Bifurcation Lesions

Clinical Trial Finds that CoreValve Reduces Rate of Death and Stroke in Sickest Patients With Aortic Stenosis

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events During Percutaneous Coronary Intervention

Zapping Renal Nerves Cuts BP Consistently

In SYNTAX, Bypass Proves Staying Power

BioMatrix Stent Better Over Longer Term

Are Dissolving Scaffolds a True Advance?

CRF Announces Late-Breaking Trials and First Report Investigations to be Presented at TCT 2013

 

More From the Meeting

Overview

Registration

Five Reasons to Attend

Attend TCT for Free

TCT Program Agenda

Virtual TCT

TCT Goes Tablet

TCT News

Week At-a-Glance

Nurse and Technologist  Symposium

Surgical Track at TCT

Satellite Symposia

Endovascular Course

Hands-on TAVR Imaging

iASSESS

Learning Labs

TCT in 3

Late-Breaking Trials

About San Francisco

Travel and Airfare

Airport Transportation

TCT Shuttle

Shuttle Schedule

Housing

 

 

Submit a Comment

Your email address will not be published. Required fields are marked *

two × 5 =

[ HIDE/SHOW ]